Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gaulard

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Leukemia|May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphomaA Bouchekioua, L Scourzic, O de Wever, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Histopathology|July 23, 2008
Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 casesJ Diebold, A Le Tourneau, B Marmey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA studyL de Leval, C Bonnet, C Copie-Bergman, et al.
Leukemia|July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximabJ-P Jais, C Haioun, T J Molina, et al.
Journal of Clinical Pathology|September 17, 2008
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)D de Jong, W Xie, A Rosenwald, et al.
Oncogene|November 17, 2005
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomasB Ballester, O Ramuz, C Gisselbrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Leukemia|March 4, 2005
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphomaT Marafioti, M Pozzobon, M-L Hansmann, et al.
The American Journal of Surgical Pathology|February 16, 1999
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)T Petrella, S Dalac, M Maynadié, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Leukemia|May 22, 2013
JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphomaA Bouchekioua, L Scourzic, O de Wever, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2005
Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'AdulteP Feugier, A Van Hoof, C Sebban, et al.
Histopathology|July 23, 2008
Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 casesJ Diebold, A Le Tourneau, B Marmey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA studyL de Leval, C Bonnet, C Copie-Bergman, et al.
Leukemia|July 11, 2008
The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximabJ-P Jais, C Haioun, T J Molina, et al.
Journal of Clinical Pathology|September 17, 2008
Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium)D de Jong, W Xie, A Rosenwald, et al.
Oncogene|November 17, 2005
Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomasB Ballester, O Ramuz, C Gisselbrecht, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Leukemia|March 4, 2005
Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphomaT Marafioti, M Pozzobon, M-L Hansmann, et al.
The American Journal of Surgical Pathology|February 16, 1999
CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Français d'Etude des Lymphomes Cutanés (GFELC)T Petrella, S Dalac, M Maynadié, et al.
Pageof 18